{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:25Z","timestamp":1777870345226,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02179-0","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T07:09:57Z","timestamp":1736320197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease"],"prefix":"10.1093","author":[{"given":"Agathe","family":"Mouheb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriane","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Alencar de Pinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne M.","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Alencar de Pinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doroth\u00e9e","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aghil\u00e8s","family":"Hamroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves-Edouard","family":"Herpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriane","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Schantsra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Hannedouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Mailliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00e9tan","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Magnant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Deroure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Lacraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Lambrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Philippe","family":"Bourdenx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Essig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lobbedez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hac\u00e8ne","family":"Sekhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Smati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Delahousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Landru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Belenfant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Urena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Panescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Glowacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryvonne","family":"Hourmant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Besnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Juillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2179_CR1","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"SV Badve","year":"2020","unstructured":"Badve SV, Pascoe EM, Tiku A et al (2020) Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 382:2504\u20132513. https:\/\/doi.org\/10.1056\/NEJMoa1915833","journal-title":"N Engl J Med"},{"key":"2179_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/bjd.16365","volume":"179","author":"G Chaby","year":"2018","unstructured":"Chaby G, Valeyrie-Allanore L, Duong TA et al (2018) Severe cutaneous adverse reactions due to inappropriate medication use. Br J Dermatol 179:329\u2013336. https:\/\/doi.org\/10.1111\/bjd.16365","journal-title":"Br J Dermatol"},{"key":"2179_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2020.01.001","volume":"74","author":"A Brucato","year":"2020","unstructured":"Brucato A, Cianci F, Carnovale C (2020) Management of hyperuricemia in asymptomatic patients: a critical appraisal. Eur J Intern Med 74:8\u201317. https:\/\/doi.org\/10.1016\/j.ejim.2020.01.001","journal-title":"Eur J Intern Med"},{"key":"2179_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U et al (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5:1388\u20131393. https:\/\/doi.org\/10.2215\/CJN.01580210","journal-title":"Clin J Am Soc Nephrol"},{"key":"2179_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","volume":"66","author":"D Sircar","year":"2015","unstructured":"Sircar D, Chatterjee S, Waikhom R et al (2015) Efficacy of febuxostat for slowing the GFR decline in patients With CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 66:945\u2013950. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.017","journal-title":"Am J Kidney Dis"},{"key":"2179_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","volume":"53","author":"M Madero","year":"2009","unstructured":"Madero M, Sarnak MJ, Wang X et al (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53:796\u2013803. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.021","journal-title":"Am J Kidney Dis"},{"key":"2179_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13075-019-2011-y","volume":"21","author":"A Rey","year":"2019","unstructured":"Rey A, Batteux B, Laville SM et al (2019) Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study. Arthritis Res Ther 21:229. https:\/\/doi.org\/10.1186\/s13075-019-2011-y","journal-title":"Arthritis Res Ther"},{"key":"2179_CR8","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/bcp.13738","volume":"84","author":"SM Laville","year":"2018","unstructured":"Laville SM, Metzger M, Stengel B et al (2018) Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol 84:2811\u20132823. https:\/\/doi.org\/10.1111\/bcp.13738","journal-title":"Br J Clin Pharmacol"},{"key":"2179_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12877-020-1485-4","volume":"20","author":"C Roux-Marson","year":"2020","unstructured":"Roux-Marson C, Baranski JB, Fafin C et al (2020) Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr 20:87. https:\/\/doi.org\/10.1186\/s12877-020-1485-4","journal-title":"BMC Geriatr"},{"key":"2179_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney inter, Suppl 3:1\u2013150","journal-title":"Kidney inter, Suppl"},{"key":"2179_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/art.41710","volume":"73","author":"S Suissa","year":"2021","unstructured":"Suissa S, Suissa K, Hudson M (2021) Effectiveness of allopurinol in reducing mortality: time-related biases in observational studies. Arthritis Rheumatol 73:1749\u20131757. https:\/\/doi.org\/10.1002\/art.41710","journal-title":"Arthritis Rheumatol"},{"key":"2179_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12882-015-0047-z","volume":"16","author":"T Kanji","year":"2015","unstructured":"Kanji T, Gandhi M, Clase CM, Yang R (2015) Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol 16:58. https:\/\/doi.org\/10.1186\/s12882-015-0047-z","journal-title":"BMC Nephrol"},{"key":"2179_CR13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T et al (2020) 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res 72:744\u2013760. https:\/\/doi.org\/10.1002\/acr.24180","journal-title":"Arthritis Care Res"},{"key":"2179_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.17179\/excli2018-1256","volume":"17","author":"MNA Mukri","year":"2018","unstructured":"Mukri MNA, Kong W-Y, Mustafar R et al (2018) Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: a 6-months open-label, randomized controlled trial. EXCLI J 17:563\u2013575. https:\/\/doi.org\/10.17179\/excli2018-1256","journal-title":"EXCLI J"},{"key":"2179_CR15","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1038\/s41598-023-30902-7","volume":"13","author":"M Prezelin-Reydit","year":"2023","unstructured":"Prezelin-Reydit M, Combe C, Fouque D et al (2023) Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease. Sci Rep 13:3952. https:\/\/doi.org\/10.1038\/s41598-023-30902-7","journal-title":"Sci Rep"},{"key":"2179_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S et al (2018) Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72:798\u2013810. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.028","journal-title":"Am J Kidney Dis"},{"key":"2179_CR17","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","author":"A Doria","year":"2020","unstructured":"Doria A, Galecki AT, Spino C et al (2020) Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 382:2493\u20132503. https:\/\/doi.org\/10.1056\/NEJMoa1916624","journal-title":"N Engl J Med"},{"key":"2179_CR18","doi-asserted-by":"publisher","first-page":"10734","DOI":"10.1038\/s41598-020-67026-1","volume":"10","author":"Y-L Peng","year":"2020","unstructured":"Peng Y-L, Tain Y-L, Lee C-T et al (2020) Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease. Sci Rep 10:10734. https:\/\/doi.org\/10.1038\/s41598-020-67026-1","journal-title":"Sci Rep"},{"key":"2179_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/ndt\/gft388","volume":"29","author":"B Stengel","year":"2014","unstructured":"Stengel B, Combe C, Jacquelinet C et al (2014) The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transplant 29:1500\u20131507. https:\/\/doi.org\/10.1093\/ndt\/gft388","journal-title":"Nephrol Dial Transplant"},{"key":"2179_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2215\/CJN.01030120","volume":"15","author":"SM Laville","year":"2020","unstructured":"Laville SM, Gras-Champel V, Moragny J et al (2020) Adverse drug reactions in patients with CKD. Clin J Am Soc Nephrol 15:1090\u20131102. https:\/\/doi.org\/10.2215\/CJN.01030120","journal-title":"Clin J Am Soc Nephrol"},{"key":"2179_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1053\/j.ajkd.2023.09.012","volume":"83","author":"SM Laville","year":"2024","unstructured":"Laville SM, Gras-Champel V, Hamroun A et al (2024) Kidney function decline and serious adverse drug reactions in patients with CKD. Am J Kidney Dis 83:601-614.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2023.09.012","journal-title":"Am J Kidney Dis"},{"key":"2179_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","volume":"15","author":"MA Hern\u00e1n","year":"2004","unstructured":"Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15:615\u2013625. https:\/\/doi.org\/10.1097\/01.ede.0000135174.63482.43","journal-title":"Epidemiology"},{"key":"2179_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/ije\/dyw341","volume":"45","author":"J Textor","year":"2017","unstructured":"Textor J, van der Zander B, Gilthorpe MS et al (2017) Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol 45:1887\u20131894. https:\/\/doi.org\/10.1093\/ije\/dyw341","journal-title":"Int J Epidemiol"},{"key":"2179_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3238\/arztebl.2016.0092","volume":"112","author":"F Hoffmann","year":"2015","unstructured":"Hoffmann F, Boeschen D, D\u00f6rks M et al (2015) Renal Insufficiency and Medication in Nursing Home Residents - a cross-sectional study (IMREN). Dtsch \u00c4rztebl Int 112:92\u2013108. https:\/\/doi.org\/10.3238\/arztebl.2016.0092","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"2179_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12875-022-01931-4","volume":"23","author":"S Ruiz-Boy","year":"2022","unstructured":"Ruiz-Boy S, Rodriguez-Reyes M, Clos-Soldevila J, Rovira-Illamola M (2022) Appropriateness of drug prescriptions in patients with chronic kidney disease in primary care: a double-center retrospective study. BMC Prim Care 23:323. https:\/\/doi.org\/10.1186\/s12875-022-01931-4","journal-title":"BMC Prim Care"},{"key":"2179_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.kint.2024.05.033","volume":"106","author":"RJ Johnson","year":"2024","unstructured":"Johnson RJ, Mandell BF, Schlesinger N et al (2024) Controversies and practical management of patients with gout and chronic kidney disease. Kidney Int 106:573\u2013582. https:\/\/doi.org\/10.1016\/j.kint.2024.05.033","journal-title":"Kidney Int"},{"key":"2179_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain P-D, Mockenhaupt M et al (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58:25\u201332. https:\/\/doi.org\/10.1016\/j.jaad.2007.08.036","journal-title":"J Am Acad Dermatol"},{"key":"2179_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1681\/ASN.2004030208","volume":"16","author":"S Domrongkitchaiporn","year":"2005","unstructured":"Domrongkitchaiporn S, Sritara P, Kitiyakara C et al (2005) Risk factors for development of decreased kidney function in a southeast asian population: a 12-Year Cohort Study. J Am Soc Nephrol 16:791\u2013799. https:\/\/doi.org\/10.1681\/ASN.2004030208","journal-title":"J Am Soc Nephrol"},{"key":"2179_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jch.13239","volume":"20","author":"SE Mwasongwe","year":"2018","unstructured":"Mwasongwe SE, F\u00fcl\u00f6p T, Katz R et al (2018) Relation of uric acid level to rapid kidney function decline and development of kidney disease: The Jackson Heart Study. J Clin Hypertens 20:775\u2013783. https:\/\/doi.org\/10.1111\/jch.13239","journal-title":"J Clin Hypertens"},{"key":"2179_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Inoue T et al (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642\u2013650. https:\/\/doi.org\/10.1016\/S0272-6386(04)00934-5","journal-title":"Am J Kidney Dis"},{"key":"2179_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","volume":"169","author":"C Hsu","year":"2009","unstructured":"Hsu C, Iribarren C, McCulloch CE et al (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169:342\u2013350. https:\/\/doi.org\/10.1001\/archinternmed.2008.605","journal-title":"Arch Intern Med"},{"key":"2179_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1681\/ASN.0000000000000352","volume":"35","author":"DB Mount","year":"2024","unstructured":"Mount DB (2024) Requiem for urate lowering in CKD? J Am Soc Nephrol 35:525\u2013527. https:\/\/doi.org\/10.1681\/ASN.0000000000000352","journal-title":"J Am Soc Nephrol"},{"key":"2179_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1681\/ASN.0000000000000326","volume":"35","author":"HJL Heerspink","year":"2024","unstructured":"Heerspink HJL, Stack AG, Terkeltaub R et al (2024) Combination treatment with verinurad and allopurinol in CKD: a randomized placebo and active controlled Trial. J Am Soc Nephrol 35:594\u2013606. https:\/\/doi.org\/10.1681\/ASN.0000000000000326","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:09Z","timestamp":1777564449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/2\/597\/8307198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":33,"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02179-0","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M., S.M.L., S.L., O.L., M.L. have nothing to declare. Z.A.M. reports having received grants for CKD-REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka, AstraZeneca, Vifor and the French government, as well as fees and grants to charities from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. N.A.P. declares financial support from pharmaceutical companies who are members of the CKD-REIN public\u2013private partnership: Fresenius Medical Care, GlaxoSmithKline, Vifor France, and Boehringer Ingelheim; all grants were made to Paris Saclay University. D.F. has received grants and lecture fees from Astellas, GlaxoSmithKline, Dr Schar, Theradial, and AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the institutional review board at the French National Institute of Health and medical research (INSERM; reference: IRB00003888).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Patients provided informed consent to participate.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}